This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
Talk to your healthcare provider to see if you are an ideal candidate for these drugs
Thyroid disorders may be linked to conditions like diabetes and obesity
These apps offer varying levels of detail, user-friendliness, and additional features beyond basic protein tracking
Understanding the Expiration Date on Tirzepatide Every medication comes with an expiration date, but for injectable peptides like tirzepatide, this date is more than just a suggestion